Migration of cultured vascular smooth muscle cells into non-crosslinked fibrin gels

Thrombosis Research

Volumn 84, Issue 2, 1996, Pages 129-136

  Naito, Michitaka ^a   Nomura, Hideki ^a   Iguchi, Akihisa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

atherosclerosis; crosslinking; fibrin gel; migration; smooth muscle cell; thrombosis

Indexed keywords

ANTITHROMBIN III; APROTININ; FIBRIN; HIRUDIN; THROMBIN; TRANEXAMIC ACID;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CATTLE; CELL MIGRATION; CONTROLLED STUDY; FIBRIN CLOT; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; THROMBOSIS; VASCULAR SMOOTH MUSCLE;

EID: 0030588258     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00168-5     Document Type: Article

References (30)

1. SCHWARTZ C.J., VALENTE A.J., KELLEY J.L., SPRAGUE E.A., EDWARDS E.H. Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin Thromb Hemostasis. 14:1988;189-195.
2. DUGUID J.B. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J Pathol Bacteriol. 58:1946;207-212.
3. BINI A., FENOGLIO J.J., SOBEL J., OWEN J., FEJGI M., KAPLAN K.L. Immunochemical characterization of fibrinogen, fibrin I and fibrin II in human thrombi and atherosclerotic lesions. Blood. 69:1987;1038-1045.
4. BINI A., FENOGLIO J.J., MESA-TEJADA R., KUDRYK B., KAPLAN K.L. Identification and distribution of fibrinogen, fibrin and fibrin(ogen) degradation products in atherosclerosis. Arteriosclerosis. 9:1989;109-121.
5. SHEKHONIN B.V., TARARAK E.M., SAMOKHIN G.P., MITKEVICH O.V., MAZUROV A.V., VINOGRADOV D.V., VLASIK T.N., KALANTAROV G.F., KOTELIANSKY V.E. Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis. Atherosclerosis. 82:1990;213-226.
6. NAITO M., HAYASHI T., IGUCHI A. New approaches to the prevention of atherosclerosis. Drugs. 50:1995;440-453.
7. SMITH E.B., THOMPSON W.D. Fibrin as a factor in atherogenesis. Thromb Res. 73:1994;1-19.
8. RABBANI L.E., LOSCALZO J. Recent observations on the role of hemostatic determinants in the development of the atherosclerotic plaque. Atherosclerosis. 105:1994;1-7.
9. NIEWIAROWSKI S., RAO A.K. Contribution of thrombogenic factors to the pathogenesis of atherosclerosis. Prog Cardiovasc Dis. 26:1983;197-222.
10. WOOLF N. Thrombosis and atherosclerosis. Br Med Bull. 34:1979;137-142.
11. ROSS R., GLOMSET J.A. The pathogenesis of atherosclerosis, (part 1). N Engl J Med. 295:1976;369-377.
12. ROSS R., GLOMSET J.A. The pathogenesis of atherosclerosis, (part 2). N Engl J Med. 295:1976;420-425.
13. NAITO M., FUNAKI C., HAYASHI T., YAMADA K., ASAI K., YOSHIMINE N., KUZUYA F. Substrate-bound fibrinogen, fibrin and other cell attachment-promoting proteins as a scaffold for cultured vascular smooth muscle cells. Atherosclerosis. 96:1992;227-234.
14. NAITO M., HAYASHI T., KUZUYA M., FUNAKI C., ASAI K., KUZUYA F. Fibrinogen is chemotactic for vascular smooth muscle cells. FEBS Lett. 247:1989;358-360.
15. NAITO M., HAYASHI T., KUZUYA M., FUNAKI C., ASAI K., KUZUYA F. Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. Atherosclerosis. 83:1990;9-14.
16. SCHWARTZ M.L., PIZZO S.V., HILL R.L., McKEE P.A. The effect of fibrin stabilizing factor on the subunit structure of human fibrin. J Clin Invest. 50:1971;1506-1513.
17. KANNEL W.B., D'AGOSTINO R.B., BELANGER A.J. Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol. 2:1992;457-466.
18. ERNST E., RESCH K.L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 118:1993;956-963.
19. ERNST E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis. 100:1993;1-12.
20. DAWES K.E., GRAY A.J., LAURENT G.J. Thrombin stimulates fibroblast chemotaxis and replication. Eur J Cell Biol. 61:1993;126-130.
21. BROWN L.F., LANIR N., McDONAGH J., TOGNAZZI K., DVORAK A.M., DVORAK H. Fibroblast migration in fibrin gel matrices. Am J Pathol. 142:1993;273-283.
22. JACKSON C.L., RAINES E., ROSS R., REIDY M.A. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 13:1993;1218-1226.
23. BENDECK M.P., ZEMPO N., CLOWES A.W., GALARDY R.E., REIDY M.A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 75:1994;539-545.
24. ISHIDA T., TANAKA K. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture. Atherosclerosis. 44:1982;161-174.
25. SCHLEEF R.R., BIRDWELL C.R. Biochemical changes in endothelial cell monolayers induced by fibrin deposition in vitro. Arteriosclerosis. 3:1984;14-20.
26. WATANABE K., TANAKA K. Influences of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells. Atherosclerosis. 48:1983;57-70.
27. MONTESANO R., PEPPER M.S., VASSALLI J.-D., ORCI L. Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. J Cell Physiol. 132:1987;509-516.
28. ROSS R., RAINES E.W., BOWEN-POPE D.F. The biology of platelet-derived growth factor. Cell. 46:1986;155-169.
29. ROSS R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
30. RAINES E.W., ROSS R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J. 69:1993;S30-S37.